WHO Battles Sexual Misconduct and Abusive Behaviour, Sets Mid-November Deadline for Action Plan 13/10/2023 Chetan Bhattacharji In the wake of an abuse scandal that led to the removal of its regional director, WHO’s Western Pacific Regional Office on Friday announced a series of new measures to combat abusive behaviour and sexual exploitation among the region’s over 600 staff. Last March, in an unprecedented move, some countries in the 37-member region voted […] Continue reading -> Norway’s Global Health Ambassador to Lead Wellcome Foundation 11/10/2023 Kerry Cullinan Norway’s Ambassador for Global Health, Dr John-Arne Røttingen, has been appointed CEO of the charitable foundation Wellcome, one of the world’s largest funders of science aimed at solving urgent health issues, the body announced on Wednesday. Røttingen, who will assume the position in January 2024, has had a versatile and varied career. He started out […] Continue reading -> PEPFAR Limps into Uncertain Future after Failure of US Congress to Authorise Five-Year Plan 04/10/2023 Kerry Cullinan The failure of the US Congress to reauthorise a five-year budget for the world’s largest aid programme for global health, the US President’s Emergency Plan for AIDS Relief (PEPFAR), by its 30 September deadline doesn’t mean that it will automatically end – but without broad bipartisan support, it limps into an uncertain future. “In the […] Continue reading -> Leaders Suggest UN May Be More Appropriate to Lead Pandemic Response Than WHO 20/09/2023 Kerry Cullinan NEW YORK – Despite the weaknesses of the political declaration on Pandemic Prevention, Preparedness, and Response (PPPR) expected to be adopted by the United Nations (UN) High-Level Meeting (HLM) on Wednesday, some world leaders believe that the UN is a more appropriate forum to thrash out the global pandemic response than the World Health Organization […] Continue reading -> The African Union in the G20: What Will the Implications Be For Health Financing in Africa? 19/09/2023 Justice Nonvignon, Boima S. Kamara, Pete Baker, Javier Guzman & Jean Kaseya Health systems in Africa are under considerable strain: rapid demographic change, rising non-communicable diseases, and emerging and re-emerging threats such as COVID-19 and Ebola are increasing demands on limited health services. Africa, however, faces a challenging period in health financing to meet these increasing needs. Health spending in most countries remains far short of what is […] Continue reading -> Shenanigans in WHO South-East Asia as Politician’s Daughter Contests Regional Director Election 18/09/2023 Mukesh Kapila Election fever is sweeping through the World Health Organization (WHO) in three of its six regions – Eastern Mediterranean (EMRO), South-East Asia (SEARO), and Western Pacific (WPRO). It matters who becomes their regional directors because they have considerable decentralised authority to influence the health chances of billions. Its regions also make or break WHO globally. […] Continue reading -> WHO Fires Another Senior Official for Sexual Misconduct 07/09/2023 Kerry Cullinan The World Health Organization (WHO) has dismissed Dr Maurizio Barbeschi, former head of its Health Security Unit, for sexual misconduct after a three-year investigation that started in January 2020, according to The Telegraph. Barbeschi had been on administrative leave since late 2021 as the global body investigated complaints against him, including that he removed his […] Continue reading -> Achieving Gender Parity in Global Health Governance ‘Is Not Enough’ 15/08/2023 Paula Dupraz-Dobias The World Health Organization’s (WHO) Director-General Dr Tedros Adhanom Ghebreyesus recently announced he would not run to be the next United Nations (UN) Secretary General, adding that a woman should take that role. But what is the state of women’s representation in global health governance, and what does gender parity entail? Last week, Tedros told […] Continue reading -> Equitable Drug Access and Finance Are Looming Issues in Talks on International Health Regulations 28/07/2023 Elaine Ruth Fletcher The thorny and unresolved issues of how to incorporate health equity measures and supportive finance for low and middle income countries into revisions of the WHO International Health Regulations (IHR), are set to be two key items on the agenda of an IHR negotiating body when talks resume again in early October. This was one […] Continue reading -> Some Cancer Drugs Excluded from New WHO Essential Medicines List Because of Cost 26/07/2023 Kerry Cullinan High cost has prevented some cancer drugs from being included in the World Health Organization’s (WHO) updated Essential Medicines List (EML) and Essential Medicines for List Children (EMLc) released on Wednesday. These include “patented, highly-priced” treatments for lung and breast cancer. “With the cancer medicines, we are facing now an issue where we have a […] Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy Loading Comments... You must be logged in to post a comment.
Norway’s Global Health Ambassador to Lead Wellcome Foundation 11/10/2023 Kerry Cullinan Norway’s Ambassador for Global Health, Dr John-Arne Røttingen, has been appointed CEO of the charitable foundation Wellcome, one of the world’s largest funders of science aimed at solving urgent health issues, the body announced on Wednesday. Røttingen, who will assume the position in January 2024, has had a versatile and varied career. He started out […] Continue reading -> PEPFAR Limps into Uncertain Future after Failure of US Congress to Authorise Five-Year Plan 04/10/2023 Kerry Cullinan The failure of the US Congress to reauthorise a five-year budget for the world’s largest aid programme for global health, the US President’s Emergency Plan for AIDS Relief (PEPFAR), by its 30 September deadline doesn’t mean that it will automatically end – but without broad bipartisan support, it limps into an uncertain future. “In the […] Continue reading -> Leaders Suggest UN May Be More Appropriate to Lead Pandemic Response Than WHO 20/09/2023 Kerry Cullinan NEW YORK – Despite the weaknesses of the political declaration on Pandemic Prevention, Preparedness, and Response (PPPR) expected to be adopted by the United Nations (UN) High-Level Meeting (HLM) on Wednesday, some world leaders believe that the UN is a more appropriate forum to thrash out the global pandemic response than the World Health Organization […] Continue reading -> The African Union in the G20: What Will the Implications Be For Health Financing in Africa? 19/09/2023 Justice Nonvignon, Boima S. Kamara, Pete Baker, Javier Guzman & Jean Kaseya Health systems in Africa are under considerable strain: rapid demographic change, rising non-communicable diseases, and emerging and re-emerging threats such as COVID-19 and Ebola are increasing demands on limited health services. Africa, however, faces a challenging period in health financing to meet these increasing needs. Health spending in most countries remains far short of what is […] Continue reading -> Shenanigans in WHO South-East Asia as Politician’s Daughter Contests Regional Director Election 18/09/2023 Mukesh Kapila Election fever is sweeping through the World Health Organization (WHO) in three of its six regions – Eastern Mediterranean (EMRO), South-East Asia (SEARO), and Western Pacific (WPRO). It matters who becomes their regional directors because they have considerable decentralised authority to influence the health chances of billions. Its regions also make or break WHO globally. […] Continue reading -> WHO Fires Another Senior Official for Sexual Misconduct 07/09/2023 Kerry Cullinan The World Health Organization (WHO) has dismissed Dr Maurizio Barbeschi, former head of its Health Security Unit, for sexual misconduct after a three-year investigation that started in January 2020, according to The Telegraph. Barbeschi had been on administrative leave since late 2021 as the global body investigated complaints against him, including that he removed his […] Continue reading -> Achieving Gender Parity in Global Health Governance ‘Is Not Enough’ 15/08/2023 Paula Dupraz-Dobias The World Health Organization’s (WHO) Director-General Dr Tedros Adhanom Ghebreyesus recently announced he would not run to be the next United Nations (UN) Secretary General, adding that a woman should take that role. But what is the state of women’s representation in global health governance, and what does gender parity entail? Last week, Tedros told […] Continue reading -> Equitable Drug Access and Finance Are Looming Issues in Talks on International Health Regulations 28/07/2023 Elaine Ruth Fletcher The thorny and unresolved issues of how to incorporate health equity measures and supportive finance for low and middle income countries into revisions of the WHO International Health Regulations (IHR), are set to be two key items on the agenda of an IHR negotiating body when talks resume again in early October. This was one […] Continue reading -> Some Cancer Drugs Excluded from New WHO Essential Medicines List Because of Cost 26/07/2023 Kerry Cullinan High cost has prevented some cancer drugs from being included in the World Health Organization’s (WHO) updated Essential Medicines List (EML) and Essential Medicines for List Children (EMLc) released on Wednesday. These include “patented, highly-priced” treatments for lung and breast cancer. “With the cancer medicines, we are facing now an issue where we have a […] Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy Loading Comments... You must be logged in to post a comment.
PEPFAR Limps into Uncertain Future after Failure of US Congress to Authorise Five-Year Plan 04/10/2023 Kerry Cullinan The failure of the US Congress to reauthorise a five-year budget for the world’s largest aid programme for global health, the US President’s Emergency Plan for AIDS Relief (PEPFAR), by its 30 September deadline doesn’t mean that it will automatically end – but without broad bipartisan support, it limps into an uncertain future. “In the […] Continue reading -> Leaders Suggest UN May Be More Appropriate to Lead Pandemic Response Than WHO 20/09/2023 Kerry Cullinan NEW YORK – Despite the weaknesses of the political declaration on Pandemic Prevention, Preparedness, and Response (PPPR) expected to be adopted by the United Nations (UN) High-Level Meeting (HLM) on Wednesday, some world leaders believe that the UN is a more appropriate forum to thrash out the global pandemic response than the World Health Organization […] Continue reading -> The African Union in the G20: What Will the Implications Be For Health Financing in Africa? 19/09/2023 Justice Nonvignon, Boima S. Kamara, Pete Baker, Javier Guzman & Jean Kaseya Health systems in Africa are under considerable strain: rapid demographic change, rising non-communicable diseases, and emerging and re-emerging threats such as COVID-19 and Ebola are increasing demands on limited health services. Africa, however, faces a challenging period in health financing to meet these increasing needs. Health spending in most countries remains far short of what is […] Continue reading -> Shenanigans in WHO South-East Asia as Politician’s Daughter Contests Regional Director Election 18/09/2023 Mukesh Kapila Election fever is sweeping through the World Health Organization (WHO) in three of its six regions – Eastern Mediterranean (EMRO), South-East Asia (SEARO), and Western Pacific (WPRO). It matters who becomes their regional directors because they have considerable decentralised authority to influence the health chances of billions. Its regions also make or break WHO globally. […] Continue reading -> WHO Fires Another Senior Official for Sexual Misconduct 07/09/2023 Kerry Cullinan The World Health Organization (WHO) has dismissed Dr Maurizio Barbeschi, former head of its Health Security Unit, for sexual misconduct after a three-year investigation that started in January 2020, according to The Telegraph. Barbeschi had been on administrative leave since late 2021 as the global body investigated complaints against him, including that he removed his […] Continue reading -> Achieving Gender Parity in Global Health Governance ‘Is Not Enough’ 15/08/2023 Paula Dupraz-Dobias The World Health Organization’s (WHO) Director-General Dr Tedros Adhanom Ghebreyesus recently announced he would not run to be the next United Nations (UN) Secretary General, adding that a woman should take that role. But what is the state of women’s representation in global health governance, and what does gender parity entail? Last week, Tedros told […] Continue reading -> Equitable Drug Access and Finance Are Looming Issues in Talks on International Health Regulations 28/07/2023 Elaine Ruth Fletcher The thorny and unresolved issues of how to incorporate health equity measures and supportive finance for low and middle income countries into revisions of the WHO International Health Regulations (IHR), are set to be two key items on the agenda of an IHR negotiating body when talks resume again in early October. This was one […] Continue reading -> Some Cancer Drugs Excluded from New WHO Essential Medicines List Because of Cost 26/07/2023 Kerry Cullinan High cost has prevented some cancer drugs from being included in the World Health Organization’s (WHO) updated Essential Medicines List (EML) and Essential Medicines for List Children (EMLc) released on Wednesday. These include “patented, highly-priced” treatments for lung and breast cancer. “With the cancer medicines, we are facing now an issue where we have a […] Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy Loading Comments... You must be logged in to post a comment.
Leaders Suggest UN May Be More Appropriate to Lead Pandemic Response Than WHO 20/09/2023 Kerry Cullinan NEW YORK – Despite the weaknesses of the political declaration on Pandemic Prevention, Preparedness, and Response (PPPR) expected to be adopted by the United Nations (UN) High-Level Meeting (HLM) on Wednesday, some world leaders believe that the UN is a more appropriate forum to thrash out the global pandemic response than the World Health Organization […] Continue reading -> The African Union in the G20: What Will the Implications Be For Health Financing in Africa? 19/09/2023 Justice Nonvignon, Boima S. Kamara, Pete Baker, Javier Guzman & Jean Kaseya Health systems in Africa are under considerable strain: rapid demographic change, rising non-communicable diseases, and emerging and re-emerging threats such as COVID-19 and Ebola are increasing demands on limited health services. Africa, however, faces a challenging period in health financing to meet these increasing needs. Health spending in most countries remains far short of what is […] Continue reading -> Shenanigans in WHO South-East Asia as Politician’s Daughter Contests Regional Director Election 18/09/2023 Mukesh Kapila Election fever is sweeping through the World Health Organization (WHO) in three of its six regions – Eastern Mediterranean (EMRO), South-East Asia (SEARO), and Western Pacific (WPRO). It matters who becomes their regional directors because they have considerable decentralised authority to influence the health chances of billions. Its regions also make or break WHO globally. […] Continue reading -> WHO Fires Another Senior Official for Sexual Misconduct 07/09/2023 Kerry Cullinan The World Health Organization (WHO) has dismissed Dr Maurizio Barbeschi, former head of its Health Security Unit, for sexual misconduct after a three-year investigation that started in January 2020, according to The Telegraph. Barbeschi had been on administrative leave since late 2021 as the global body investigated complaints against him, including that he removed his […] Continue reading -> Achieving Gender Parity in Global Health Governance ‘Is Not Enough’ 15/08/2023 Paula Dupraz-Dobias The World Health Organization’s (WHO) Director-General Dr Tedros Adhanom Ghebreyesus recently announced he would not run to be the next United Nations (UN) Secretary General, adding that a woman should take that role. But what is the state of women’s representation in global health governance, and what does gender parity entail? Last week, Tedros told […] Continue reading -> Equitable Drug Access and Finance Are Looming Issues in Talks on International Health Regulations 28/07/2023 Elaine Ruth Fletcher The thorny and unresolved issues of how to incorporate health equity measures and supportive finance for low and middle income countries into revisions of the WHO International Health Regulations (IHR), are set to be two key items on the agenda of an IHR negotiating body when talks resume again in early October. This was one […] Continue reading -> Some Cancer Drugs Excluded from New WHO Essential Medicines List Because of Cost 26/07/2023 Kerry Cullinan High cost has prevented some cancer drugs from being included in the World Health Organization’s (WHO) updated Essential Medicines List (EML) and Essential Medicines for List Children (EMLc) released on Wednesday. These include “patented, highly-priced” treatments for lung and breast cancer. “With the cancer medicines, we are facing now an issue where we have a […] Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy Loading Comments... You must be logged in to post a comment.
The African Union in the G20: What Will the Implications Be For Health Financing in Africa? 19/09/2023 Justice Nonvignon, Boima S. Kamara, Pete Baker, Javier Guzman & Jean Kaseya Health systems in Africa are under considerable strain: rapid demographic change, rising non-communicable diseases, and emerging and re-emerging threats such as COVID-19 and Ebola are increasing demands on limited health services. Africa, however, faces a challenging period in health financing to meet these increasing needs. Health spending in most countries remains far short of what is […] Continue reading -> Shenanigans in WHO South-East Asia as Politician’s Daughter Contests Regional Director Election 18/09/2023 Mukesh Kapila Election fever is sweeping through the World Health Organization (WHO) in three of its six regions – Eastern Mediterranean (EMRO), South-East Asia (SEARO), and Western Pacific (WPRO). It matters who becomes their regional directors because they have considerable decentralised authority to influence the health chances of billions. Its regions also make or break WHO globally. […] Continue reading -> WHO Fires Another Senior Official for Sexual Misconduct 07/09/2023 Kerry Cullinan The World Health Organization (WHO) has dismissed Dr Maurizio Barbeschi, former head of its Health Security Unit, for sexual misconduct after a three-year investigation that started in January 2020, according to The Telegraph. Barbeschi had been on administrative leave since late 2021 as the global body investigated complaints against him, including that he removed his […] Continue reading -> Achieving Gender Parity in Global Health Governance ‘Is Not Enough’ 15/08/2023 Paula Dupraz-Dobias The World Health Organization’s (WHO) Director-General Dr Tedros Adhanom Ghebreyesus recently announced he would not run to be the next United Nations (UN) Secretary General, adding that a woman should take that role. But what is the state of women’s representation in global health governance, and what does gender parity entail? Last week, Tedros told […] Continue reading -> Equitable Drug Access and Finance Are Looming Issues in Talks on International Health Regulations 28/07/2023 Elaine Ruth Fletcher The thorny and unresolved issues of how to incorporate health equity measures and supportive finance for low and middle income countries into revisions of the WHO International Health Regulations (IHR), are set to be two key items on the agenda of an IHR negotiating body when talks resume again in early October. This was one […] Continue reading -> Some Cancer Drugs Excluded from New WHO Essential Medicines List Because of Cost 26/07/2023 Kerry Cullinan High cost has prevented some cancer drugs from being included in the World Health Organization’s (WHO) updated Essential Medicines List (EML) and Essential Medicines for List Children (EMLc) released on Wednesday. These include “patented, highly-priced” treatments for lung and breast cancer. “With the cancer medicines, we are facing now an issue where we have a […] Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy Loading Comments... You must be logged in to post a comment.
Shenanigans in WHO South-East Asia as Politician’s Daughter Contests Regional Director Election 18/09/2023 Mukesh Kapila Election fever is sweeping through the World Health Organization (WHO) in three of its six regions – Eastern Mediterranean (EMRO), South-East Asia (SEARO), and Western Pacific (WPRO). It matters who becomes their regional directors because they have considerable decentralised authority to influence the health chances of billions. Its regions also make or break WHO globally. […] Continue reading -> WHO Fires Another Senior Official for Sexual Misconduct 07/09/2023 Kerry Cullinan The World Health Organization (WHO) has dismissed Dr Maurizio Barbeschi, former head of its Health Security Unit, for sexual misconduct after a three-year investigation that started in January 2020, according to The Telegraph. Barbeschi had been on administrative leave since late 2021 as the global body investigated complaints against him, including that he removed his […] Continue reading -> Achieving Gender Parity in Global Health Governance ‘Is Not Enough’ 15/08/2023 Paula Dupraz-Dobias The World Health Organization’s (WHO) Director-General Dr Tedros Adhanom Ghebreyesus recently announced he would not run to be the next United Nations (UN) Secretary General, adding that a woman should take that role. But what is the state of women’s representation in global health governance, and what does gender parity entail? Last week, Tedros told […] Continue reading -> Equitable Drug Access and Finance Are Looming Issues in Talks on International Health Regulations 28/07/2023 Elaine Ruth Fletcher The thorny and unresolved issues of how to incorporate health equity measures and supportive finance for low and middle income countries into revisions of the WHO International Health Regulations (IHR), are set to be two key items on the agenda of an IHR negotiating body when talks resume again in early October. This was one […] Continue reading -> Some Cancer Drugs Excluded from New WHO Essential Medicines List Because of Cost 26/07/2023 Kerry Cullinan High cost has prevented some cancer drugs from being included in the World Health Organization’s (WHO) updated Essential Medicines List (EML) and Essential Medicines for List Children (EMLc) released on Wednesday. These include “patented, highly-priced” treatments for lung and breast cancer. “With the cancer medicines, we are facing now an issue where we have a […] Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy Loading Comments... You must be logged in to post a comment.
WHO Fires Another Senior Official for Sexual Misconduct 07/09/2023 Kerry Cullinan The World Health Organization (WHO) has dismissed Dr Maurizio Barbeschi, former head of its Health Security Unit, for sexual misconduct after a three-year investigation that started in January 2020, according to The Telegraph. Barbeschi had been on administrative leave since late 2021 as the global body investigated complaints against him, including that he removed his […] Continue reading -> Achieving Gender Parity in Global Health Governance ‘Is Not Enough’ 15/08/2023 Paula Dupraz-Dobias The World Health Organization’s (WHO) Director-General Dr Tedros Adhanom Ghebreyesus recently announced he would not run to be the next United Nations (UN) Secretary General, adding that a woman should take that role. But what is the state of women’s representation in global health governance, and what does gender parity entail? Last week, Tedros told […] Continue reading -> Equitable Drug Access and Finance Are Looming Issues in Talks on International Health Regulations 28/07/2023 Elaine Ruth Fletcher The thorny and unresolved issues of how to incorporate health equity measures and supportive finance for low and middle income countries into revisions of the WHO International Health Regulations (IHR), are set to be two key items on the agenda of an IHR negotiating body when talks resume again in early October. This was one […] Continue reading -> Some Cancer Drugs Excluded from New WHO Essential Medicines List Because of Cost 26/07/2023 Kerry Cullinan High cost has prevented some cancer drugs from being included in the World Health Organization’s (WHO) updated Essential Medicines List (EML) and Essential Medicines for List Children (EMLc) released on Wednesday. These include “patented, highly-priced” treatments for lung and breast cancer. “With the cancer medicines, we are facing now an issue where we have a […] Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy Loading Comments... You must be logged in to post a comment.
Achieving Gender Parity in Global Health Governance ‘Is Not Enough’ 15/08/2023 Paula Dupraz-Dobias The World Health Organization’s (WHO) Director-General Dr Tedros Adhanom Ghebreyesus recently announced he would not run to be the next United Nations (UN) Secretary General, adding that a woman should take that role. But what is the state of women’s representation in global health governance, and what does gender parity entail? Last week, Tedros told […] Continue reading -> Equitable Drug Access and Finance Are Looming Issues in Talks on International Health Regulations 28/07/2023 Elaine Ruth Fletcher The thorny and unresolved issues of how to incorporate health equity measures and supportive finance for low and middle income countries into revisions of the WHO International Health Regulations (IHR), are set to be two key items on the agenda of an IHR negotiating body when talks resume again in early October. This was one […] Continue reading -> Some Cancer Drugs Excluded from New WHO Essential Medicines List Because of Cost 26/07/2023 Kerry Cullinan High cost has prevented some cancer drugs from being included in the World Health Organization’s (WHO) updated Essential Medicines List (EML) and Essential Medicines for List Children (EMLc) released on Wednesday. These include “patented, highly-priced” treatments for lung and breast cancer. “With the cancer medicines, we are facing now an issue where we have a […] Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy Loading Comments... You must be logged in to post a comment.
Equitable Drug Access and Finance Are Looming Issues in Talks on International Health Regulations 28/07/2023 Elaine Ruth Fletcher The thorny and unresolved issues of how to incorporate health equity measures and supportive finance for low and middle income countries into revisions of the WHO International Health Regulations (IHR), are set to be two key items on the agenda of an IHR negotiating body when talks resume again in early October. This was one […] Continue reading -> Some Cancer Drugs Excluded from New WHO Essential Medicines List Because of Cost 26/07/2023 Kerry Cullinan High cost has prevented some cancer drugs from being included in the World Health Organization’s (WHO) updated Essential Medicines List (EML) and Essential Medicines for List Children (EMLc) released on Wednesday. These include “patented, highly-priced” treatments for lung and breast cancer. “With the cancer medicines, we are facing now an issue where we have a […] Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy Loading Comments... You must be logged in to post a comment.
Some Cancer Drugs Excluded from New WHO Essential Medicines List Because of Cost 26/07/2023 Kerry Cullinan High cost has prevented some cancer drugs from being included in the World Health Organization’s (WHO) updated Essential Medicines List (EML) and Essential Medicines for List Children (EMLc) released on Wednesday. These include “patented, highly-priced” treatments for lung and breast cancer. “With the cancer medicines, we are facing now an issue where we have a […] Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy